Inogen to Present at Upcoming Investor Conferences in November 2023
Inogen Expands Its Respiratory Product Portfolio with Acquisition of Physio-Assist
Inogen Expands Its Respiratory Product Portfolio with Acquisition of Physio-Assist
Inogen 2023 Third Quarter Financial Results
Quarter Ended Sep 30, 2023
For complete information regarding our financials, see our periodic filings
Inogen Stockholder Engagement Presentation 2023
Inogen, Inc. (Nasdaq: INGN) is a leading global medical technology company offering innovative respiratory products for use in the homecare setting. Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available allowing patients the chance to remain ambulatory while managing the impact of their disease.
View Company Profile